Adaptimmune Announces Changes to Board of Directors
April 12, 2018 08:00 ET
|
Adaptimmune Therapeutics plc
PHILADELPHIA, Pa. and OXFORD, U.K., April 12, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that, in a planned...